- Open Access
Phospholipids and sports performance
© Jäger et al; licensee BioMed Central Ltd. 2007
- Received: 30 May 2007
- Accepted: 25 July 2007
- Published: 25 July 2007
Phospholipids are essential components of all biological membranes. Phosphatidylcholine (PC) and Phosphatidylserine (PS) are Phosphatidyl-phospholipids that are required for normal cellular structure and function. The participation in physical activity often challenges a variety of physiological systems; consequently, the ability to maintain normal cellular function during activity can determine sporting performance. The participation in prolonged intense exercise has been shown to reduce circulatory choline concentrations in some individuals. As choline is a pre-cursor to the neurotransmitter Acetylcholine, this finding has encouraged researchers to investigate the hypothesis that supplementation with PC (or choline salts) could enhance sporting performance. Although the available data that evaluates the effects of PC supplementation on performance are equivocal, acute oral supplementation with PC (~0.2 g PC per kg body mass) has been demonstrated to improve performance in a variety of sporting activities where exercise has depleted circulatory choline concentrations. Short term oral supplementation with soy-derived PS (S-PS) has been reported to attenuate circulating cortisol concentrations, improve perceived well-being, and reduce perceived muscle soreness after exercise. More recently, short term oral supplementation (750 mg per day of S-PS for 10 days) has been demonstrated to improve exercise capacity during high intensity cycling and tended to increase performance during intermittent running. Although more research is warranted to determine minimum dietary Phospholipid requirements for optimal sporting performance, these findings suggest that some participants might benefit from dietary interventions that increase the intakes of PC and PS.
- Muscle Soreness
- Creatine Kinase Activity
- Race Time
- Choline Level
The functional ingredients of Lecithin are Phosphorus containing lipids called Phospholipids (PL). Hundreds of different PL molecules have been described, but the major types are the phosphatidyl-phospholipids. They consist of two fatty acids groups that are connected through a glycerol backbone to a Phosphate ester group. Phospholipids are essential building blocks of all biological membrane systems and act not only as structural molecules but also as dynamic, functionally important components of cells .
Phosphatidylcholine (PC) is a major constituent of all cellular membranes and its presence is necessary for normal function. Phosphatidylcholine builds a continuous membrane matrix, providing precise fluidity, charge distribution and electronic character that enzymes and other membrane molecules need to carry out their functions. Supplies of PC are needed to support membrane expansion as the cells grow, for membrane renewal, and for the regeneration of the cells' membrane system following damage. Phosphatidylcholine also operates in the liver, lungs, gastro intestinal tract and kidneys as a surface-active wetting-agent to coat cell linings. Phosphatidylcholine supplementation have been found to support healthy cholesterol levels , liver  and brain functions  and due to the essential nutrient choline, which comprises about 15% of the PC molecule, PC supplementation might be beneficial for endurance athletes .
Phosphatidylserine (PS)  is present in all biological membranes of animals, higher plants and micro organisms. In humans, PS is most concentrated in the brain where it comprises 15% of the total phospholipid pool. In other human tissue the ratio of PS in the Phospholipid pool varies: lungs (7.4%), testes (6.4%), kidneys (5.7%), liver (3.8%), skeletal muscle (3.3%), heart (3.2%) and blood plasma (0.2%). The total body PS pool is estimated to be approximately 60 grams, with 30 grams in the brain and 30 grams in the rest of the body. The average daily PS intake from the diet in western countries is estimated to be 130 mg . Phosphatidylserine is located mainly in the internal layer of the cell membrane and has a variety of unique structural and regulatory functions. Phosphatidylserine is involved in governing membrane fluidity and therefore in the regulation of biological cell activities. As PS exhibits direct and indirect interactions with integral and membrane-associated proteins, it modulates the activity of receptors, enzymes, ion channels and signalling molecules. Phosphatidylserine supplementation improves brain functions that tend to decline with age . Recent studies indicate that PS supplementation might be beneficial for children with attention deficit hyperactivity disorder  and young people suffering from mental  and/or physical stress .
Intense exercise lowers choline levels
Muscle contractions are induced by signals carried along cholinergic nerves to the muscle fiber. Acetylcholine, the signaling molecule or neurotransmitter, is synthesized from choline. The concentration of free choline can influence the rates in which acetylcholine is synthesized and released [12–15]. Consequently, a reduction in free choline during intense physical activity might reduce acetylcholine release and thereby affect endurance and performance.
Phosphatidylcholine Supplementation Increases Choline Levels
The oral ingestion of inorganic choline salts (e.g. choline chloride, choline citrate, choline bitartrate) leads to losses of approximately 60% of the available choline, through conversion to trimethylamine by intestinal bacteria . The same amount of choline ingested in the form of PC produces only one third of the trimethylamine . High amounts of trimethylamine in the gastrointestinal tract can produce an offensive, fishy body odor.
Phosphatidylcholine Supplementation Prior to Activity can Prevent Decline of Choline Levels and might improve Performance
Von Allwörden reported similar findings from a double-blind, placebo-controlled, crossover pilot trial. Well-trained endurance athletes performed a cycle ergometer test for 2 hours. Subjects received either a placebo or 0.2 g PC (90%) per kg body mass at breakfast 3 hours before cycling at 1 Watt per kg body mass . Plasma choline values decreased after 2 hours of exercise by 38%. When supplemented with PC, the average plasma choline levels remained at the same level as the starting values.
Long Distance Runners
Von Allwörden investigated the effects of either placebo or 0.2 g PC (90%) per kg body mass on adolescent runners (aged 14–20 years). The subjects performed cross-country races of between 30 and 60 minutes, depending on age. Phosphatidylcholine supplementation resulted in an 18% increase in plasma choline levels with and a 54% increase without exercise; however, runners without PC supplementation did not deplete plasma choline levels .
In a follow-up trial well-trained endurance athletes (aged 25–28 years) were running with a velocity of 12 km per hour for 2 hours. Subjects received either 0.2 g PC (90%) per kg body mass at breakfast 3 hours before exercise or did not receive a controlled diet . Plasma choline values decreased after 2 hours of running by an average of 55%. When supplemented with PC average plasma choline levels increased during three hours of rest. Physical stress lowered choline levels by 41%; however, final values were still higher than initial values. Lactic acid values with PC supplementation were lower in 8 out of 10 runners and time to recover was 12% shorter.
More recently, Buchman et al. reported that supplementation with PC, in the form of lecithin, attenuated the exercise-induced reduction of plasma choline concentrations in marathon runners when compared to supplementation with a placebo . Actual race times were not different from predicted race times and the authors concluded that supplementation failed to improve performance. This comparison should be viewed with caution as race times during marathon running are difficult to predict due to variations in courses and environmental conditions.
Studies with choline salts
In a double-blind, crossover, placebo-controlled clinical trial ten long distance runners received either 2.8 g choline citrate or placebo 1 hour prior to and again after completing 10 miles of a 20 mile run . Plasma choline levels were reported to have increased in the choline supplemented group, whereas they decreased in the placebo group after strenuous exercise. The mean run time was found to be significantly shorter when runners were supplemented with choline when compared to placebo, being 153.7 minutes and 158.9 minutes, respectively.
Spector at al. investigated the relationships between plasma choline and fatigue during supramaximal brief and submaximal prolonged cycling activities . In a placebo-controlled trial choline bitartrate supplementation resulted in an increase in choline plasma levels. Neither group depleted choline during either brief or prolonged cycling training. Fatigue times and work performed were similar under both conditions in each group. It was concluded that choline was not depleted in either condition nor did choline supplementation delay fatigue.
Deuster et al. investigated the effects of choline supplementation on treadmill exercise in a double-blind crossover study . Choline supplementation significantly increased plasma choline concentrations. Exhaustive physical activity did not deplete circulating choline levels and consequently did not affect physical or cognitive performance.
These findings confirm Warber et al.'s double-blind crossover study on choline citrate in which soldiers did not deplete plasma choline levels and did not delay fatigue during a four hour load carriage treadmill exercise .
Overtraining is a natural hazard of competitive sports. The consequences of this condition can include decreased performance, injury, depressed immunity and psychological depression [32, 33]. A serious corollary of overtraining in young female athletes is its propensity to decrease bone density . During early stages of overtraining, such as when you work too hard during one or two exercise sessions, muscles become sore, resting and submaximal exercise heart rate and cortisol levels increase and testosterone levels fall. The body has difficulties in adjusting, but usually recovers with a few days' rest. Chronic overtraining often creates a disturbance in the ratio between the anabolic hormone, testosterone, and the catabolic hormone cortisol.
Phosphatidylserine was historically obtained from bovine cortex (BC-PS). Due to the potential transfer of infectious disease, this supplement is now considered unsuitable. More recently, soy-derived phosphatidylserine (S-PS) has become accepted as a safe alternative. Soy-PS is commercially available as an oral supplement, with recommended daily doses usually ranging from 100 to 500 mg.
Several double-blind, placebo-controlled clinical trials have been performed to investigate whether phosphatidylserine supplementation (BC-PS and S-PS) prior to exercise can prevent the exercise-induced increase in cortisol levels and improve other markers related to hard training.
In a double-blind, randomized, placebo-controlled, cross-over design, Monteleone et al.  showed that PS supplementation suppressed cortisol and ACTH responses to staged cycling exercise. Compared to placebo, cortisol levels were 30% lower (800 mg S-PS), demonstrating that PS supplementation can lessen the severity of stress responses to exercise.
Kingsley et al.  recently reported a double-blind, placebo-controlled clinical trial where fourteen active males completed staged intermittent exercise on three separate occasions, (a familiarization trial followed by two main trials that were separated by approximately 16 days). The staged intermittent protocol consisted of three 10-min stages of cycling at 45, 55 and 65% VO2max followed by a final bout at 85% VO2max that was continued until exhaustion. The exercise time to exhaustion was used as a measure of exercise capacity. After completing the first main trial the subjects consumed either 750 mg of S-PS per day or a placebo for 10 days. The main finding was that supplementation influenced exercise capacity at 85% VO2max. The group that received S-PS increased exercise times to exhaustion by 29 ± 8%, while the exercise times to exhaustion did not change following supplementation with placebo. Nevertheless, supplementation did not significantly influence oxygen kinetic responses (MRTon or MRToff), substrate oxidation, cortisol, and feeling states during the trial.
A more recent double-blind, randomised, placebo-controlled, crossover study investigated the effects of S-PS supplementation on markers of muscle damage, inflammation, muscle soreness and oxidative stress following eccentric exercise-induced muscle damage . Independent of supplementation with S-PS (750 mg per day for 10 days) or placebo, downhill running induced similar increases in circulating CK activities, myoglobin concentrations, interleukin-6 concentrations and hydroperoxide concentrations.
Kingsley et al.  investigated the effects of oral supplementation with 750 mg per day of S-PS for 10 days on oxidative stress caused by exhaustive intermittent running that was designed to simulate the movement patterns of soccer with the addition of a performance run at the end of the protocol. Although supplementation did not influence lipid peroxidation (as measured by hydroperoxide concentrations), muscle damage (as measured by circulatory CK activities and myoglobin concentrations) and perceived muscle soreness, supplementation with S-PS tended to improve sprint and exercise performances when compared to placebo. This double-blind, placebo-controlled clinical trial demonstrated a potential ergogenic property of S-PS.
Phosphatidylserine and Mental Stress
Mental and physical stress is closely linked and results in similar physiological responses in the human body. Forty-eight male undergraduate students received either 300 mg S-PS or placebo for 30 days. Mental stress was induced by performing a demanding mathematical task. Phosphatidylserine supplementation resulted in improvements in feeling clear-headed, composed and confident, feeling energetic and elated in a specific sub-section of the young healthy students .
Hellhammer et al. investigated the effects of a three week soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) supplementation to a mental and emotional stressor . 400 mg PAS resulted in a pronounced blunting of serum ACTH and cortisol levels as well as positive effects on emotional responses compared to placebo, however, higher doses (600 mg and 800 mg) did not result in the same effects.
Phosphatidylserine has a long history in improving brain functions that tend to decline with age. Numerous clinical trials with PS have showed improvements in memory tasks such as name-face delayed recall, facial recognition, telephone-number recall and misplaced-objects recall . Phosphatidylserine supplementation has been reported to improve long-term memory, long-term recognition, as well as free speech and logic speaking . It has been observed that the interest in the environment and the attention span were increased while loss of motivation, socialization and initiative were reduced .
Plasma choline levels can decrease during intense physical activity of long duration. Where circulating choline concentrations have been demonstrated to decrease during physical activity, choline supplementation has shown benefit in improving performance.
The effective dosage in sport studies is 0.2 g PC (90%) per kg body mass, which equals 2.1 g of choline for an 80 kg athlete. There is no requirement for a loading or maintenance phase and supplementation up to one hour before exercise has been shown to be effective.
Phosphatidylserine has been demonstrated to be an effective supplement for combating exercise-induced stress and preventing the physiological deterioration that accompanies too much exercise (i.e. overtraining). Studies examining athletes involved in cycling, weight training and endurance running suggest that PS might speed up recovery, prevent muscle soreness, improve well-being, and might possess ergogenic properties. Under some circumstances, PS has been reported to suppress cortisol. This might protect muscle membranes against phospholipase damage, which is formed in response to muscle trauma. In addition, PS could increase the rate of glucose transported into muscle cells and, therefore, enhance recovery of muscle glycogen following strenuous exercise.
The effective dosages in sport studies range from 300 to 800 mg PS per day for short-term application (10 -15 days). The effective dosage for mental stress, which is closely related to physical stress, is 300 mg PS per day for 30 days. However, long-term studies on cognitive functions have found significant physiological effects using daily dosages as low as 100 mg PS per day. The lowest effective dose for athletes is unknown.
Many of the richest dietary sources of PC and PS are also high in cholesterol and fat. Egg yolk, meat and internal organs are good sources of phospholipids. Whereas grains, fruits and vegetables are relatively low in PC and PS. Modern Diets are depleted of phospholipids (primarily refined oils and fats, dehulled and cleaned raw materials). These changes in diet (low fat, low Cholesterol), as well as the BSE crises (mad cow disease), have led to a decrease in daily PS and PC consumption. Today's foods contain approximately one third of the phospholipid levels compared to the beginning of last century , which could increase the athletes need for proper nutrition and/or supplementation.
The authors would like to thank Chemi Nutra, 4463 White Bear Pkwy, Suite 105, White Bear Lake, MN 55110, USA, for funding the manuscript publication.
- Hanahan DJ, Nelson DR: Phospholipids as dynamic participants in biological processes. J Lipid Res. 1984, 25: 1528-1535.PubMedGoogle Scholar
- Wojcicki J, Pawlik A, Samochowiec L, Kaldonska M, Mysliwiec Z: Clinical evaluation of lecithin as lipid-lowering agent. Phytother Res. 1995, 9 (8): 597-599. 10.1002/ptr.2650090814.View ArticleGoogle Scholar
- Knüchel F: Doppelblindstudie bei Patienten mit alkoholischer Fettleber. Med Welt. 1979, 30: 411-416.PubMedGoogle Scholar
- Sitaram N, Weingartner H, Gillin JC: Human serial learning: enhancement with arecholine and choline impairment with scopolamine. Science. 1978, 201: 274-276. 10.1126/science.351808.View ArticlePubMedGoogle Scholar
- Von Allwörden HN, Horn S, Kahl J, Feldheim W: The influence of lecithin on plasma choline concentrations in triathletes and adolescent runners during exercise. Eur J Appl Physiol. 1993, 67 (1): 87-91. 10.1007/BF00377711.View ArticleGoogle Scholar
- Folch J: Brain Cephalin, a mixture of Phosphatides. Separation from it of Phosphatidyl serine, Phosphatidyl ethanolamine, and a fraction containing an inositol Phosphatide. J Biol Chem. 1942, 146 (1): 35-44.Google Scholar
- Souci SW, Fachmann E, Kraut H: Food Composition and Nutrition Tables. Stuttgart. 2000, Medpharm Scientific PublishersGoogle Scholar
- Louis-Sylvestre J: Phosphatidylserine and memory problems in aged subjects. Cah Nutr Diet. 1999, 34 (6): 349-357.Google Scholar
- Kidd PM: Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Altern Med Rev. 2000, 5 (5): 402-428.PubMedGoogle Scholar
- Benton D, Donohoe RT, Sillance B, Nabb S: The Influence of Phosphatidylserine Supplementation on Mood and Heart Rate when Faced with an Acute Stressor. Nutr Neurosci. 2001, 4 (3): 169-178.PubMedGoogle Scholar
- Monteleone P, Beinat L, Tanzillo C, Maj M, Kemali D: Effects of Phosphatidylserine on the Neuroendocrine Response to Physical Stress in Humans. Neuroendocrinology. 1990, 52 (3): 243-248.View ArticlePubMedGoogle Scholar
- Haubrich DR, Wedeking PW, Wang PFL: Increase in tissue concentration of acetylcholine in guinea pigs in vivo induced by administration of choline. Life Sci. 1974, 14 (5): 921-927. 10.1016/0024-3205(74)90081-2.View ArticlePubMedGoogle Scholar
- Haubrich DR, Wang PFL, Clody DE, Wedeking PW: Increase in rat brain acetylcholine induced by choline or deanol. Life Sci. 1975, 17 (6): 975-980. 10.1016/0024-3205(75)90451-8.View ArticlePubMedGoogle Scholar
- Wecker L: The synthesis and release of acetylcholine by depolarized hippocampal slices is increased by increased choline availability in vitro prior to stimulation. J Neurochem. 1991, 57 (4): 1119-1127. 10.1111/j.1471-4159.1991.tb08269.x.View ArticlePubMedGoogle Scholar
- Trommer BA, Schmidt DE, Wecker L: Exogenous choline enhances the synthesis of acetylcholine only under conditions of increased cholinergic neuronal activity. J Neurochem. 1982, 39 (6): 1704-1709. 10.1111/j.1471-4159.1982.tb08006.x.View ArticlePubMedGoogle Scholar
- Conlay LA, Wurtman RJ, Blusztajn JK, Coviella ILG, Maher TJ, Evoniuk GE: Decreased Plasma Choline Concentrations in Marathon Runners. N Engl J Med. 1986, 315 (14): 892-PubMedGoogle Scholar
- Conlay LA, Sabounjian LA, Wurtman RJ: Exercise and Neuromodulators: Choline and Acetylcholine in Marathon Runners. Int J Sports Med. 1992, 13: S141-S142.View ArticlePubMedGoogle Scholar
- Von Allwörden HN, Horn S, Feldheim W: The Influence of Lecithin on the Performance and the Recovery Process of Endurance Athletes. Phospholipids: Characterization, Metabolism, and Novel Biological Applications. Edited by: Cevc G, Paltauf F. 1995, Champaign: AOCS Press, 319-325.Google Scholar
- Sandage BW, Sabounjian RN, White R, Wurtman RJ: Choline citrate may enhance athletic performance [abstract]. Physiologist. 1992, 35 (4): 236-Google Scholar
- Buchman AL, Jenden D, Roch M: Plasma free, phospholipid-bound and urinary free choline all decrease during a marathon run and may be associated with impaired performance. J Am Coll Nutr. 1999, 18 (6): 598-601.View ArticlePubMedGoogle Scholar
- Wurtman RJ, Hirsch MJ, Growdon JH: Lecithin consumption raises serum-free-choline levels. Lancet. 1977, 2: 68-69. 10.1016/S0140-6736(77)90067-8.View ArticlePubMedGoogle Scholar
- Hirsch MJ, Growdon JH, Wurtman RJ: Relations between dietary choline or lecithin intake, serum choline levels, and various metabolic indices. Metabolism. 1978, 27 (8): 953-960. 10.1016/0026-0495(78)90139-7.View ArticlePubMedGoogle Scholar
- De la Huerga J, Popper H: Urinary excretion of choline metabolites following choline administration in normals and patients with hepatobiliary diseases. J Clin Invest. 1951, 30 (5): 463-470.PubMed CentralView ArticlePubMedGoogle Scholar
- De la Huerga J, Popper H: Factors influencing choline absorption in the intestinal tract. J Clin Invest. 1952, 31 (6): 598-603.PubMed CentralView ArticlePubMedGoogle Scholar
- Lucia A, Hoyos J, Perez M, Chicharro JL: Heart rate and performance parameters in elite cyclists: a longitudinal study. Med Sci Sports Exerc. 2000, 32 (10): 1777-1782. 10.1097/00005768-200010000-00018.View ArticlePubMedGoogle Scholar
- Mies H: Über den Einfluβ des Lecithins auf den Erholungsvorgang. Münch med Wschr. 1958, 100 (51): 2009-2011.PubMedGoogle Scholar
- Ernst E, Mies H: Weitere Unterschungen über den Einfluβ des Lecithins auf den Erholungsvorgang. Münch med Wschr. 1960, 102 (15): 713-716.PubMedGoogle Scholar
- Buchman AL, Awal M, Jenden D, Roch M, Kang S-H: The effect of lecithin supplementation on plasma choline concentrations during a marathon. J Am Coll Nutr. 2000, 19 (6): 768-770.View ArticlePubMedGoogle Scholar
- Spector SA, Jackman MR, Sabounjian LA, Sakkas C, Landers DM, Willis W: Effect of choline supplementation on fatigue in trained cyclists. Med Sci Sports Exerc. 1995, 27 (5): 668-673.View ArticlePubMedGoogle Scholar
- Deuster PA, Singh A, Coll R, Hyde DE, Becker WJ: Choline ingestion does not modify physical or cognitive performance. Mil Med. 2002, 167 (12): 1020-1025.PubMedGoogle Scholar
- Warber JP, Patton JF, Tharion WJ, Zeisel SH, Mello RP, Kemnitz CP, Lieberman HR: The effects of choline supplementation on physical performance. Int J Sport Nutr Exerc Metab. 2000, 10 (2): 170-181.PubMedGoogle Scholar
- Fahey TD: Biological markers of overtraining. Biol Sport. 1997, 14: 1-19.Google Scholar
- Kuipers H, Keizer HA: Overtraining and elite athletes: Review and directions for the future. Sports Med. 1988, 6: 79-92.View ArticlePubMedGoogle Scholar
- Kang L, Belcher D, Hulstyn MJ: Stress fractures of the femoral shaft in women's college lacrosse: a report of seven cases and a review of the literature. Br J Sports Med. 2005, 39: 902-906. 10.1136/bjsm.2004.016626.PubMed CentralView ArticlePubMedGoogle Scholar
- Monteleone P, Maj M, Beinat L, Natale M, Kemali D: Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharmacol. 1992, 42 (4): 385-388.PubMedGoogle Scholar
- Kingsley M, Miller M, Kilduff LP, McEneny J, Benton D: Effects of phosphatidylserine on exercise capacity during cycling in active males. Med Sci Sports Exerc. 2006, 38 (1): 64-71. 10.1249/01.mss.0000183195.10867.d0.View ArticlePubMedGoogle Scholar
- Fahey TD, Pearl MS: The Hormonal and Perceptive Effects of Phosphatidylserine Administration During Two Weeks of Weight Training-Induced Over-Training. Biol Sport. 1998, 15 (2): 135-144.Google Scholar
- Fernholz KM, Seifert JG, Bacharach DW, Burke ER, Gazal O: The Effects of Phosphatidyl Serine on Markers of Muscular Stress in Endurance Runners [abstract]. Med Sci Sports Exerc. 2000, 32 (5): S321-Google Scholar
- Kingsley M, Kilduff LP, McEneny J, Dietzig RE, Benton D: Phosphatidylserine supplementation and recovery following downhill running. Med Sci Sports Exerc. 2006, 38 (9): 1617-1625. 10.1249/01.mss.0000229459.11452.a0.View ArticlePubMedGoogle Scholar
- Kingsley M, Wadsworth D, Kilduff LP, McEneny J, Benton D: Effects of phosphatidylserine on oxidative stress following intermittent running. Med Sci Sports Exerc. 2005, 37 (8): 1300-1306. 10.1249/01.mss.0000175306.05465.7e.View ArticlePubMedGoogle Scholar
- Hellhammer J, Fries E, Buss C, Engert V, Tuch A, Rutenberg D, Hellhammer D: Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress. Stress. 2004, 7 (2): 119-126.View ArticlePubMedGoogle Scholar
- Crook TH, Tinklenberg J, Yesavage J, Petrie W, Nunzi MG, Massari DC: Effects of Phosphatidylserine in age-associated memory impairment. Neurol. 1991, 41: 644-649.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.